Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) today announced their agreement with Molecular Targeting Technologies, Inc. (MTTI), a clinical stage biotech company focused on developing innovative...
Edifecs, Inc., a health information technology solutions company, has signed a definitive agreement to acquire Health Fidelity, a leading provider of risk adjustment solutions...
CytoReason, an Israeli company developing computational disease models for more efficient drug discovery and development, today announced a collaboration with German multinational science and...
